Sjögren Syndrome
13
1
1
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
15.4%
2 terminated out of 13 trials
83.3%
-3.2% vs benchmark
31%
4 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (13)
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
N-acetylcysteine for Primary Sjögren's Syndrome
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome
Pelvic Floor Exercises in Patients With Sjögren's
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome
Comparison Between Rebamipide 2% Versus Autologous Serum
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study